top of page

Validators & Suppot Studies

Bibliography

Informe Huella Económica y Sostenibilidad Financiera Industria Farmacéutica Colombia 20211118

Introducing plasma fractionation Altran

Key-economic-and-value-considerations-for-plasma-derived-medicinal-products-PDMPs-in-Europe_Vintura-and-PPTA

Overview Fractionation Burnouf

Events

Africa Webinar 2023

Africa Webinar 2023

IPFA Amsterdam 2022

AVOIDING PLASMA WAIST

DEMAND OF IGG

EUROPEAN LEGISLATION 2

FUTURE PROJECTS FOR PLASMA

LFB EXPERIENCE

PLASMA DONOR PANEL

PUBLIC SUPPORT OF PLASMA

TENDERS FOR SUFFIENCY

CHALENGES OF IGG IN EUROPE

CONVALESENT PLASMA PROJECT BY EBA

DONOR PERSPECTIVE ON PLASMAPHERESIS

EUROPEAN LEGISLATION

IGG AND PLASMA MARKET MRB

NEUROLOGICAL DISEASES AND IGG

PLASMA DURING PANDEMIC

QUE ES EBA European Blood Alliance

ENGLAND EXPERIENCE

EXPERIENCE OF CANADA

IMPROVING PLASMA SUPPLY

PLASMA COLLECTION AND FRACTIONATION IN EUROPE

PROPER USE OF IGG

SLOVENIA EXPERIENCE

PPTA Berlin 2022

Anti-SARS-CoV-2 Antibodies in Ig Preparations and Implications

Current hurdles and need for a global collaboration

Current market landscape for plasma and immunoglobulins

EMA’s role in global co-operation and initiatives on supply of plasma derived medicinal products_

Emerging Viruses, and Consequences for Safety and Efficacy of Plasma Products

Key-economic-and-value-considerations-for-plasma-derived-medicinal-products-PDMPs-in-Europe_Vintura-and-PPTA

Mission and role of “Arbeitskreis Blut” Pathogen Safety of Blood Components

Plasma Collection in Egypt

Plasma Collection in Ukraine

Plasma donation in Germany_ Historic overview and future outlook_

Plasma donations and PDMPs in Poland – Challenges and opportunities

Plasma Fractionation in Europe Current Situation and Past Experience

Primary Immunodeficiencies (PID) - Early Identification of Patients Matters

Setting up domestic plasma fractionation plants Lessons from the past and current realities

The Curious Case of UK Plasma

The current plans in Croatia on domestic fractionation plants

UK Plasma Alleviating the global plasma shortage

Strengers Presentation

2022-10-13 Lessons Learned of the European Ecosystem for Plasma Fractionation, Medillin, Colombia

Lessons learned from the integration of actors to

Validators

ATHI PARTICIPATION

INVEST IN RIONEGRO ANTIOQUIA COLOMBIA

MINISTRY OF HEALT LETTER

PRESS RELEASE 1

PRESS RELEASE INNOVATION RANKING SEMANA 2022

CEO PRESS INTERVIEW

MEDICAL DIRECTOR INTERVIEW

Presentation 1 from Dr. Strengers for LifeFactors

PRESS RELEASE 2

EXPERT EVENT (DR. STRENGERS)

MINISTRY OF HEAKTH LETTER 2

Presentation 2 from Dr. Strengers for LifeFactors

PRESS RELEASE INNOVATION RANKING ANDI 2022

bottom of page